“Spironolactone; the ultimate blocker of RAAS cascade in hypertensive patients with special reference to its cardiovascular benefits: Revisiting the forgotten ways” (2012) Bangladesh Journal of Medical Science, 11(2), pp. 80–86. doi:10.3329/bjms.v11i2.8664.